Compare · RR vs TMO
RR vs TMO
Side-by-side comparison of Richtech Robotics Inc. (RR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RR and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $195.56B, about 546.6x RR ($357.8M).
- Over the past year, RR is down 23.3% and TMO is up 29.9% - TMO leads by 53.2 points.
- TMO has hit the wire 7 times in the past 4 weeks while RR has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 2 for RR).
- Company
- Richtech Robotics Inc.
- Thermo Fisher Scientific Inc
- Price
- $1.60-0.93%
- $526.23-1.11%
- Market cap
- $357.8M
- $195.56B
- 1M return
- -23.26%
- +13.98%
- 1Y return
- -23.26%
- +29.90%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2023
- News (4w)
- 0
- 7
- Recent ratings
- 2
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest RR
- Richtech Robotics Launches Interactive Livestream Featuring AI-Powered Robot ADAM, Enabling Online Users to Engage with ADAM
- Richtech Robotics Selected as Featured Exhibitor in First-Ever Humanoid Pavilion at Automate 2026
- Richtech Robotics to Debut Latest AI-Driven Pallet Jack Robot During Keynote Session at Automate 2026 in Chicago
- Richtech Robotics to Showcase Dual-Armed AI-Powered ADAM and DUST-E S Autonomous Cleaning Robots at HITEC 2026
- Richtech Robotics Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
- Richtech Robotics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
- Richtech Robotics Completes Strategic Acquisition of Warehouse Facility in Las Vegas to Accommodate Robotics and AI Powered Growth Objectives
- Richtech Robotics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
- Richtech Robotics Receives Notification from Nasdaq Regarding Late Filing of Form 10-Q
- SEC Form NT 10-Q filed by Richtech Robotics Inc.
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target